Sapna Srivastava
CIK 1569226 · last filed 2026-07-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.33M
Companies
8
Total Filings
34
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NUVL | Director | 0 | $123.96 | $0 | $0 | 7 | 2026-07-15 |
| ALMS | Director | 3,553 | $27.03 | $96.0K | $0 | 3 | 2026-07-02 |
| AURA | Director | 38,500 | $7.05 | $271.4K | $0 | 6 | 2026-06-15 |
| Tourmaline Bio, Inc. (TRML) Delisted | Director | 0 | $47.98 | $0 | $0 | 3 | 2025-10-28 |
| INVA | Director | 44,096 | $21.81 | $961.7K | $0 | 2 | 2024-06-20 |
| SQZ Biotechnologies Co (SQZ) Delisted | Director | — | $0.43 | — | $0 | 4 | 2023-06-15 |
| Tourmaline Bio, Inc. (TALS) Delisted | Director | — | $27.20 | — | $0 | 2 | 2023-06-14 |
| MedAvail Holdings, Inc. (MYOS) Delisted | Director | — | — | — | $0 | 1 | 2015-01-12 |
Recent Filings · Page 2 of 4
34 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-24 | AURA | Grant (A) | +10,500 | $0 | EDGAR |
| 2024-06-20 | INVA | Grant (A) | +13,923 | $0 | EDGAR |
| 2024-06-14 | NUVL | Grant (A) | +2,499 | $0 | EDGAR |
| 2024-06-07 | Tourmaline Bio, Inc. (TRML) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-10-23 | — | Mixed | +518 | $0 | |
| 2023-06-16 | NUVL | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | SQZ Biotechnologies Co (SQZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-14 | Tourmaline Bio, Inc. (TALS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | AURA | Grant (A) | — | $0 | EDGAR |
| 2023-05-24 | INVA | Grant (A) | +16,495 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.